Predictors of Pulmonary Hypertension in Patients With End-Stage Heart Failure

Congestive Heart Failure

Volumn 18, Issue 4, 2012, Pages 212-216

  Torres Macho, Juan ^a   Delgado Jiménez, Juan F ^a   Sanz Salvo, Javier ^a   González Mansilla, Ana ^a   Sánchez Sánchez, Violeta ^a   Gámez Díez, Sergio ^a   Escribano Subías, Pilar ^a   Sáenz de la Calzada, Carlos ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; LUNG PRESSURE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TRICUSPID VALVE REGURGITATION; VASCULAR RESISTANCE;

DISEASE PROGRESSION; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; HYPERTENSION, PULMONARY; LOGISTIC MODELS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SYSTOLE; TRICUSPID VALVE INSUFFICIENCY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84864068788     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2011.00277.x     Document Type: Article

References (30)

1. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493-2537.
2. Oudiz RJ. Pulmonary hypertension associated with left-sided heart disease. Clin Chest Med. 2007;28:233-241.
3. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/ AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association Developed in Collaboration With the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53:1573-1619.
4. Bourge RC, Naftel DC, Costanzo-Nordin MR, et al. Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group. J Heart Lung Transplant. 1993;12:549-562.
5. Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992;19:48-54.
6. Murali S, Kormos RL, Uretsky BF, et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J. 1993;126:896-904.
7. Chen JM, Levin HR, Michler RE, et al. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg. 1997;114:627-634.
8. Abramson SV, Burke JF, Kelly JJ, et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med. 1992;116: 888-895.
9. Costanzo MR, Augustine S, Bourge R, et al. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1995;92: 3593-3612.
10. Erickson KW, Costanzo-Nordin MR, O'Sullivan EJ, et al. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant. 1990;9:526-537.
11. Hosenpud JD, Bennett LE, Keck BM, et al. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000. J Heart Lung Transplant. 2000;19:909-931.
12. Delgado JF, Gomez-Sanchez MA, Saenz de la Calzada C, et al. Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. J Heart Lung Transplant. 2001;20:942-948.
13. Chang PP, Longenecker JC, Wang NY, et al. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality. J Heart Lung Transplant. 2005;24:998-1007.
14. Tenderich G, Koerner MM, Stuettgen B, et al. Does preexisting elevated pulmonary vascular resistance (transpulmonary gradient >15 mm Hg or >5 wood) predict early and long-term results after orthotopic heart transplantation? Transplant Proc. 1998;30:1130-1131.
15. Young JB, Naftel DC, Bourge RC, et al. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group. J Heart Lung Transplant. 1994;13:353-364. discussion 64-5.
16. Levine AB, Levine TB. Patient evaluation for cardiac transplantation. Prog Cardiovasc Dis. 1991;33:219-228.
17. Kawaguchi A, Gandjbakhch I, Pavie A, et al. Cardiac transplant recipients with preoperative pulmonary hypertension. Evolution of pulmonary hemodynamics and surgical options. Circulation. 1989;80:90-96.
18. Lopez-Ciudad VJ, Lopez Perez JM, Fojon Polanco S, et al. Pulmonary hypertension and early mortality after orthotopic heart transplantation. Rev Esp Cardiol. 1995;48: 552-556.
19. Butler J, Stankewicz MA, Wu J, et al. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J Heart Lung Transplant. 2005;24:170-177.
20. Khush K, Tasissa G, Butler J, et al. Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database. Am Heart J. 2009;157:1026-1034.
21. Ghio S, Gavazzi A, Campana Inserra C, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2009;53:1119-1126.
22. Delgado JF, Conde E, Sanchez V, et al. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure. Eur J Heart Fail. 2005;7:1011-1016.
23. Enriquez-Sarano M, Rossi A, Seward JB, et al. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol. 1997;29:153-159.
24. Enriquez-Sarano M, Seward JB, Bailey KR, Tajik AJ. Effective regurgitant orifice area: a noninvasive Doppler development of an old hemodynamic concept. J Am Coll Cardiol. 1994;23:443-451.
25. Junker A, Thayssen P, Nielsen B, Andersen PE. The hemodynamic and prognostic significance of echo-Doppler-proven mitral regurgitation in patients with dilated cardiomyopathy. Cardiology. 1993;23:14-20.
26. Goland S, Czer LS, Kass RM, et al. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation. J Heart Lung Transplant. 2007;26:312-318.
27. Klotz S, Schmid C, Scheld HH. Reversible pulmonary hypertension in heart transplant candidates does not obligatorily predict worse outcome post-transplantation. J Heart Lung Transplant. 2005;24:1998-1999.
28. Di Salvo TG, Mathier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol. 1995;25:1143-1153.
29. Lindelow B, Andersson B, Waagstein F, Bergh CH. High and low pulmonary vascular resistance in heart transplant candidates. A 5-year follow-up after heart transplantation shows continuous reduction in resistance and no difference in complication rate. Eur Heart J. 1999;2:148-156.
30. Leung CC, Moondra V, Catherwood E, Andrus BW. Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction. Am J Cardiol. 2010;106:284-286.